Evidence map›Paper›PMID 40563498›Full record

ReviewBiomolecules2025

Recent Advances in Monitoring Technologies for Cardiac Troponin I: A Pivotal Biomarker in Cardiovascular Diseases.

Ning Zhang, Yusong Wang, Fachuang Li, Yuxin Zhu, Zheng Fu, Mengda Jia, Xiaoran Zhan, Wanqing Zhang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ning ZhangSchool of Materials Science and Engineering, Henan Institute of Technology, Xinxiang 453003, China.
Yusong WangSchool of Chemistry and Chemical Engineering, Henan Institute of Science and Technology, Xinxiang 453003, China.
Fachuang LiSchool of Materials Science and Engineering, Henan Institute of Technology, Xinxiang 453003, China.
Yuxin ZhuSchool of Chemistry and Chemical Engineering, Henan Institute of Science and Technology, Xinxiang 453003, China.
Zheng FuSchool of Materials Science and Engineering, Henan Institute of Technology, Xinxiang 453003, China.
Mengda JiaSchool of Chemistry and Chemical Engineering, Henan Institute of Science and Technology, Xinxiang 453003, China.
Xiaoran ZhanSchool of Chemistry and Chemical Engineering, Henan Institute of Science and Technology, Xinxiang 453003, China.
Wanqing ZhangSchool of Chemistry and Chemical Engineering, Henan Institute of Science and Technology, Xinxiang 453003, China.

Funding

the Key Scientific and Technological Project of Henan Province 252102111060
6 · The paper itself

Abstract

Cardiovascular diseases (CVDs) are among the leading causes of morbidity and mortality rates globally, presenting a severe threat to human health and life. Acute myocardial infarction (AMI) is one of the most common and extremely severe disorders within CVDs, causing an estimated 17.5 million deaths each year. Cardiac troponin I (cTnI) is considered a biomarker for myocardial infarction and a "gold standard" method for diagnosing AMI due to its high specificity and sensitivity. The ability to rapidly detect cTnI with high sensitivity is critical throughout the diagnosis and treatment process of AMI. It is a necessary precursor for doctors to quickly assess the disease and initiate subsequent therapies. This work comprehensively explores various techniques for the analysis and detection of cTnI. We systematically review current cutting-edge technologies used for cTnI detection. According to optical, electrical, and intelligent technology dimensions, this study meticulously classifies and elaborates on the research progress of related sensors. Based on current research findings and technological development trends, we further project the future research directions and application prospects of cTnI sensors. This is geared towards providing valuable references for the further development of this field.

Indexed as

Biosensing TechniquesCardiovascular DiseasesTroponin IBiomarkersHumansMyocardial InfarctionBiomarkersTroponin IcTnIelectrical technologyintelligent technologyoptical technologysensor

Identifiers

PMID40563498
PMCPMC12191026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.